Apoptosis: A modulator of cellular homeostasis and disease states

Annals of the New York Academy of Sciences

Volumn 842, Issue , 1998, Pages 82-90

  Delong, Mary J ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

APOPTOSIS; CANCER; CELL DIVISION; CONFERENCE PAPER; EPITHELIUM; HOMEOSTASIS; OXIDATION REDUCTION REACTION; SALIVARY GLAND; SJOEGREN SYNDROME;

EID: 0031959190     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09635.x     Document Type: Conference Paper

References (45)

1. WYLLIE, A.H., J.F. KEER & A.R. CURRIE. 1980. Cell death: the significance of apoptosis Int. Rev. Cytol. 68: 251-305.
2. SAVILL, J. et al. 1993. Phagocytic recognition of cells undergoing apoptosis. Immunol. Today. 14: 131-136.
3. GAVRIELI, Y., Y. SHERMAN, S.A. BEN-SASSON. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J.Cell. Biol. 119: 493-501.
4. MCCONKEY, D.J. & S. ORRENIUS. 1996. Signal transduction pathways in apoptosis. Stem Cells 14: 619-631.
5. NAGATA, S. 1996. Fas-mediated apoptosis. Adv. Exp. Med. Biol. 406: 119-124.
6. FRENCH, L.E., & J. TSCHOPP. 1996. Constitutive Fas ligand expression in several non-lymphoid mouse tissues: implications for immune-protection and cell turnover. Behring Inst. Mitt. 97: 156-160.
7. KONG, L., N. OGAWA, T. NAKABAYASHI. 1997. Fas and Gas ligand expression in the salivary glands of patients with primary Sjogren's syndrome Arthritis Rheum. 40: 87-97.
8. ICHIKAWA, Y., K. ARIMORI, M. YOSHIDA et al. 1995. Abnormal expression of apoptosis-related antigens, Fas and Bcl-2 on circulating T-lymphocyte subsets in primary Sjogren's syndrome. Clin. & Exp. Rheumatol. 13: 307-313.
9. NAGATA, S. 1996. Apoptosis mediated by the Fas system. Prog. Mol. Subcell. Biol. 16: 87-103.
10. WU, A.J., Z.J. CHEN et al. 1996. Interferon-gamma induced cell death in a cultured human salivary gland cell line. J. Cell. Physiol. 167: 297-304.
11. SCHULZE-OSTHOFF, K., P.H. KRAMMER & W. DROGE. 1994. Divergent signaling via AP-1/Fas and the TNF-α receptor, two homologous molecules involved in physiological cell death. EMBO J. 13: 4587-4596.
12. KORSMEYER, S.J., X.M. YIN, Z.N. OLTVAI et al. 1995. Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family. Biochim. Biophys. Acta 127: 63-66.
13. HOCKENBERRY, D.M., G. NUNEZ, C. MILLIMAN et al. 1990. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (Lond.) 348: 334-336.
14. HOCKENBERRY, D.M., Z.N. OLTVAI, X.M. YIN et al 1993. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75: 241-251.
15. MOUNTZ, J.D., T. ZHOU, T. Su et al. 1996. Autoimmune disease results from multiple interactive defects in apoptosis induction molecules and signaling pathways. Behring Inst. Mitt. 97: 200-219.
16. POWIS, G., M. BRIEHL & J. OBLONG. 1995. Redox signaling and control of cell growth and death. Pharmacol. & Then 68: 149-173.
17. BUTTKE, T.M. & P.A. SANDSTROM. 1995. Redox regulation of programmed cell death in lymphocytes. Free Radical Res. Commun. 22: 389-397.
18. MCCONKEY, D.J., P. HARTZELL, P. NICOTERA et al 1988. Stimulation of endogenous endonuclease activity in hepatocytes exposed to oxidative stress. Toxicol. Lett. 42: 123-130.
19. LENNON, S.V., S.J. MARTIN, T.G. COTTER. 1990. Induction of apoptosis (programmed cell death) in tumor cells by widely diverging stimuli. Biochem. Soc. Trans. 18: 343-345.
20. FERNANDEZ, A., J. KIEFER, L. FOSDICK et al. 1995. Oxygen radical production and thiol depletion are required for Ca+2-mediated endogenous endonuclease activation in apoptotic thymocytes. J. Immunol. 155: 5133-5139.
21. SLATER, A.F., C.S. NOBEL, S. ORRENIUS. 1995. The role of intracellular oxidants in apoptosis. Biochim. Biophys. Acta 127: 59-62.
22. WOLFE, J.T., D. Ross & G.M. COHEN. 1994. A role for metals and free radicals in the induction of apoptosis in thymocytes. FEBS Lett. 352: 58-62.
23. MAYER, M. & M. NOBLE. 1994. N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vivo. Proc. Natl. Acad. Sci. USA 91: 7496-7500.
24. KANE, D.J., T.A. SARAFIAN, R. ANTON et al. 1993. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262: 1274-1277.
25. FANG, W., J.J. RIVARD, J.A. GANSER et al Bcl-xl rescues WEHI231B lymphocytes from oxidant mediated death following diverse apoptotic stimuli. J. Immunol. 155: 66-75.
26. JACOBSON, M.D. & M.C. RAFF. 1995. Programmed cell death and Bcl-2 protection in very low oxygen. Nature 37-4: 814-816.
27. SHIMIZU, S., Y. EGUCHI, H. KOSAKA et al. 1995. Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xl. Nature 374: 811-813.
28. YAO, K.S., M. CLAYTON & P.J. O'DWYER. 1995. Apoptosis in human adenocarcinoma HT-29 cells induced by exposure to hypoxia. J. Natl. Cancer Inst. 87: 117-122.
29. KAZZAZ, J.A., J. Xu, T.A. PALAIA et al. 1996. Cellular oxygen toxicity. Oxidant injury without apoptosis. J. Biol. Chem. 271: 15182-15186.
30. RICHTER, C. 1993. Pro-oxidants and mitochondrial Ca+2: their relationship to apoptosis and oncogenesis. FEBS Lett. 325: 104-107.
31. ZAMAZMI, N., P. MARCHETTI, M. CASTEDO et al. 1995. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182: 367-377.
32. ZAMZAMI, N., P. MARCHETTI, M. CASTEDO et al. 1995. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181: 1661-1672.
33. PETIT, P.X., S.A. SUSIN, N. ZAMZAMI et al. 1996. Mitochondria and programmed cell death: back to the future. FEBS Lett. 396: 7-13.
34. CASTEDO, M., T. HIRSCH, S.A. SUSIN et al. 1996. Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J. Immunol. 157: 512-521.
35. CASTEDO, M., A. MACHO, N. ZAMZAMI et al 1995. Mitochondrial perturbations define lymphocytes undergoing apoptotic depletion in vivo. Eur. J. Immunol. 25: 3277-3284.
36. RAO, L. & E. WHITE. 1997. Bcl-2 and the ICE family of apoptotic regulators: making a connection. Curr. Opin. Gen. & Dev. 7: 52-58.
37. KLUCK, R.M., E. BOSSY-WETZEL, D.R. GREEN et al 1997. The release of cytochrome C from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136.
38. YANG, J., S. LIUU, K. BHALLA et al 1997. Prevention of apoptosis by Bcl-2: release of cytochrome C from mitochondria blocked. Science 275: 1129-1132.
39. MARCHETTI, P., D. DECAUDIN, A. MACHO et al. 1997. Redox regulation of apoptosis: impact of thiol oxidation status on mitochondrial function. Eur. J. Immunol. 27: 289-296.
40. ENWONWU, C.O., & V.I. MEEKS. 1995. Bionutrition and Oral Cancer in Humans. Cri. Rev. Oral. Biol. Med. 6: 5-17.
41. ZHENG, W., X.O. SHU, B.T. JI et al. 1996. Diet and risk factors for cancer of the salivary glands: a population-based case-control study. Int. J. Cancer 67: 194-198.
42. BERGELSON, S., R. PINKUS & V. DANIEL. 1994. Intracellular glutathione levels regulate Fos/Jun induction and activation of glutathione S-transferase gene expression. Cancer Res. 54: 36-40.
43. MEYER, M., H.L. PAHL & P.A. BAEUERLE. 1994. Regulation of the transcription factors NF-kappa B and AP-1 by redox changes. Chem. Biol. Interact. 91: 91-100.
44. SHERTZER, H.G., V. VASILIOU, R-M. LIU et al 1995. Enzyme induction by L-butathionine (S,R) sulfoximine in cultured mouse hepatoma cells. Chem.Res. Toxcicol. 8: 431-436.
45. WHITFIELD, J.F. 1992. Calcium signals and cancer. Crit. Rev. Oncog. 3: 55-90.